Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 301–400 of 1,035
Fat poetry: a kingdom for PPARγ
Anghel, S. I., & Wahli, W. (2007) · Cell Research · doi:10.1038/cr.2007.48 · Cited by 186
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
“Several studies have clearly demonstrated that obese people with visceral adiposity are associated with more IR and increased morbidity than individuals with a similar degree of overall adiposity [40].”
BackgroundWISP2 regulates preadipocyte commitment and PPARγ activation by BMP4
Hammarstedt, A., Hedjazifar, S., Jenndahl, L., Gogg, S., Grünberg, J., Gustafson, B., Klimcakova, E., Stich, V., Langin, D., Laakso, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211255110 · Cited by 158
“Abdominal obesity in humans is a marker of the metabolic syndrome (13) and is also associatedwith ectopic lipid accumulation in other sites, including visceral/intraabdominal fat and the liver, as a consequence of an inability to store excessive lipids in the s.”
BackgroundFood insecurity and adult weight abnormality risk: a systematic review and meta-analysis
Moradi, S., Mirzababaei, A., Dadfarma, A., Rezaei, S., Mohammadi, H., Jannat, B., & Mirzaei, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1819-6 · Cited by 166
Herbert, D., Franz, S., Popkova, Y., Anderegg, U., Schiller, J., Schwede, K., Lorz, A., Simon, J. C., & Saalbach, A. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1522 · Cited by 158
Diabetes is a proinflammatory state: a translational perspective
Devaraj, S., Dasu, M. R., & Jialal, I. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.44 · Cited by 148
Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism
Enomoto, T., Ohashi, K., Shibata, R., Higuchi, A., Maruyama, S., Izumiya, Y., Walsh, K., Murohara, T., & Ouchi, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277319 · Cited by 152
Iron and non-alcoholic fatty liver disease
Britton, L. J., Subramaniam, V. N., & Crawford, D. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8112 · Cited by 149
Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations
Mili, N., Paschou, S. Α., Goulis, D. G., Dimopoulos, M. A., Lambrinoudaki, I. V., & Ψαλτοπούλου, Θ. (2021) · Endocrine · doi:10.1007/s12020-021-02884-x · Cited by 167
Madsen, A. N., Hansen, G., Paulsen, S. J., Lykkegaard, K., Tang-Christensen, M., Hansen, H. S., Levin, B. E., Larsen, P. J., Knudsen, L. B., Fosgerau, K., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0004 · Cited by 152
“Interestingly, a relatively high proportion of the fat accumulated as mesenteric (or central) fat, which has been described as a hallmark of the metabolic syndrome often associated with human obesity (Despres & Lemieux 2006).”
Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes
Appari, M., Channon, K. M., & McNeill, E. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7060 · Cited by 145
“However, obesity is increasingly recognized as a major contributor to IR (19).”
BackgroundXu, M., Wang, X., Yan, Y., Yao, R., & Ge, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.111 · Cited by 166
“MS is a cluster of growing epidemic diseases which present as energy metabolic disorders (obesity, diabetes) and cardiovascular diseases (hypertension, atherosclerosis) [21,22].”
BackgroundRORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network
Kim, K., Boo, K.-J., Yu, Y. S., Oh, S. K., Kim, H.-K., Jeon, Y., Bhin, J., Hwang, D., Kim, K. I., Lee, J.-S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00215-1 · Cited by 166
Cox, F. F., Misiou, A., Vierkant, A., Ale‐Agha, N., Grandoch, M., Haendeler, J., & Altschmied, J. (2022) · Cells · doi:10.3390/cells11030342 · Cited by 164
“Abdominal obesity is also linked to metabolic syndrome [74], a cluster of conditions, which is characterized by dyslipidemia, impaired glucose tolerance, and high blood pressure.”
BackgroundEating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome
Sierra‐Johnson, J., Undén, A., Linestrand, M., Rosell, M., Sjogren, P., Kolak, M., De Faire, U., Fisher, R. M., & Hellénius, M. (2008) · Obesity · doi:10.1038/oby.2008.203 · Cited by 155
“Interestingly, in our study the metabolic syndrome component that was most strongly related to meal regularity was waist circumference, which is a well-known predictor of insulin resistance (20), cardiovascular risk (1,21)”
BackgroundOthman, R. A., & Moghadasian, M. H. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00399.x · Cited by 154
Leukocyte Telomere Length and Carotid Artery Intimal Medial Thickness: The Framingham Heart Study
O’Donnell, C. J., Demissie, S., Kimura, M., Levy, D., Gardner, J. P., White, C., D’Agostino, R. B., Wolf, P. A., Polak, J., Cupples, L. A., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.154849 · Cited by 152
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 163
Cameron, A. J., Magliano, D. J., & Söderberg, S. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01051.x · Cited by 179
Influence of menopause on diabetes and diabetes risk
Szmuilowicz, E. D., Stuenkel, C. A., & Seely, E. W. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.166 · Cited by 165
“Several studies have suggested that the well-established relationships between abdominal obesity and insulin resistance in the general populatio”
Smith, J. D., Borel, A.-L., Nazare, J.-A., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J.-P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2550 · Cited by 148
Self-citationvan de Sande-Lee, S., Pereira, F. R. S., Cintra, D. E., Fernandes, P. T., Cardoso, A. R., Garlipp, C. R., Chaim, E. A., Pareja, J. C., Geloneze, B., Li, L. M., et al. (2011) · Diabetes · doi:10.2337/db10-1614 · Cited by 147
“It is the main risk factor for type 2 diabetes, atherosclerosis, and hypertension, and therefore plays an important role in the overall mortality of modern societies (2).”
BackgroundSuk, S., Kwon, G. T., Lee, E., Jang, W. J., Yang, H., Kim, J. H., Thimmegowda, N. R., Chung, M., Kwon, J. Y., Yang, S., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700139 · Cited by 143
“Obesity is characterized by the accumulation of excessive fat, which is associated with metabolic disorders [1].”
BackgroundPrevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries
Aljulifi, M. Z. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.42.5.20200676 · Cited by 163
Persistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets
Guo, J., Jou, W., Gavrilova, O., & Hall, K. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005370 · Cited by 147
Hardwick, J. P., Osei-Hyiaman, D., Wiland, H., Abdelmegeed, M. A., & Song, B.-J. (2009) · PPAR Research · doi:10.1155/2009/952734 · Cited by 148
“[20] J.”
BackgroundHigher level of faecal SCFA in women correlates with metabolic syndrome risk factors
Teixeira, T. F. S., Grześkowiak, Ł., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. C. G. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002723 · Cited by 137
Circulating omentin is associated with coronary artery disease in men
Shibata, R., Ouchi, N., Kikuchi, R., Takahashi, R., Takeshita, K., Kataoka, Y., Ohashi, K., Ikeda, N., Kihara, S., & Murohara, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.017 · Cited by 158
“Obesity, in particular, visceral at accumulation, causes a cluster of hypertension, type 2 iabetes and dyslipidemia, also referred to as metabolic synrome, ultimately leading to the development of atherosclerotic ardiovascular disease [3–8].”
BackgroundThe role of adipose tissue senescence in obesity- and ageing-related metabolic disorders
Liu, Z., Wu, K. K. L., Jiang, X., Xu, A., & Cheng, K. K. Y. (2020) · Clinical Science · doi:10.1042/cs20190966 · Cited by 137
Ursolic Acid Inhibits Adipogenesis in 3T3-L1 Adipocytes through LKB1/AMPK Pathway
He, Y., Li, Y., Zhao, T., Wang, Y., & Sun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070135 · Cited by 155
“In addition to morbidity, obesity is associated with many metabolic complications, including type-II diabetes, insulin resistance, hyperlipidemia, hypertension and coronary heart disease [1,2].”
BackgroundMaternal obesity and infant outcomes
Ruager-Martin, R., Hyde, M. J., & Modi, N. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.007 · Cited by 170
Diagnosis of obesity based on body composition‐associated health risks—Time for a change in paradigm
Bosy‐Westphal, A., & Müller, M. J. (2021) · Obesity Reviews · doi:10.1111/obr.13190 · Cited by 162
“In summary, the obesity paradox in ICU patients may be mainly explained by a protective effect of lean mass and not fat mass with a higher BMI.”
BackgroundInfluentialAndrogen metabolism in adipose tissue: Recent advances
Blouin, K., Veilleux, A., Luu-The, V., & Tchernof, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.035 · Cited by 164
The impact of liver fat vs visceral fat in determining categories of prediabetes
Kantartzis, K., Machann, J., Schick, F., Fritsche, A., Häring, H., & Stefan, N. (2010) · Diabetologia · doi:10.1007/s00125-010-1663-6 · Cited by 156
“These variables are strongly related to visceral adiposity and fatty liver, established determinants of type 2 diabetes and cardiovascular disease [12–18].”
BackgroundArner, P., Arner, E., Hammarstedt, A., & Smith, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018284 · Cited by 146
“The expanded adipose tissue mass in obesity promotes insulin resistance which, in turn, induces Type 2 diabetes in genetically susceptible individuals [2,3].”
BackgroundThe Adipocyte-Inducible Secreted Phospholipases PLA2G5 and PLA2G2E Play Distinct Roles in Obesity
Sato, H., Taketomi, Y., Ushida, A., Isogai, Y., Kojima, T., Hirabayashi, T., Miki, Y., Yamamoto, K., Nishito, Y., Kobayashi, T., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.002 · Cited by 155
“Type 2 diabetes and metabolic syndrome are increasing at an explosive rate worldwide due to a pandemic of obesity associated with insulin resistance, nonalcoholic fatty liver disease, and hyperlipidemia (Després and Lemieux, 2006).”
InfluentialFatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
Cooke, A. A., Connaughton, R. M., Lyons, C. L., McMorrow, A. M., & Roche, H. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.021 · Cited by 152
Ijaz, M. U., Ahmed, M. I., Zou, X., Hussain, M., Zhang, M., Zhao, F., Xu, X., Zhou, G., & Li, C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02200 · Cited by 151
“Metabolic syndromes is a constellation of disorders including hyperlipidemia, hyperinsulinemia, hypertension, cardiovascular diseases, and type 2 diabetes (Després et al., 2006; Eckel et al., 2010).”
BackgroundExcess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle
TUMOVA, J., ANDEL, M., & TRNKA, J. (2016) · Physiological Research · doi:10.33549/physiolres.932993 · Cited by 143
“Obesity, especially with abdominal fat distribution, is frequently associated with metabolic alterations which predispose to the development of complications such as insulin resistance, type 2 diabetes or cardiovascular diseases (Després and Lemieux 2006).”
BackgroundTakeda, S., Sato, N., Rakugi, H., & Morishita, R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00302f · Cited by 138
Lê, K., Ventura, E. E., Fisher, J. Q., Davis, J. N., Weigensberg, M. J., Punyanitya, M., Hu, P., Nayak, K. S., & Goran, M. I. (2011) · Diabetes Care · doi:10.2337/dc10-0760 · Cited by 143
Restricted Adipogenesis in Hypertrophic Obesity
Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2013) · Diabetes · doi:10.2337/db13-0473 · Cited by 142
“Inability to promote subcutaneous adipogenesis under periods of affluence would favor lipid overflow and ectopic fat accumulation with negative metabolic consequences (3,4,6).”
BackgroundMetabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Spahis, S., Borys, J.-M., & Levy, E. H. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 150
“Indeed, it is assumed that lipid overflow causes ectopic fat deposition, which impairs the function of various organs (48).”
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
Portincasa, P., Krawczyk, M. J., Smyk, W., Lammert, F., & Ciaula, A. D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13338 · Cited by 148
CB1 antagonists for obesity—what lessons have we learned from rimonabant?
Marzo, V. D., & Després, J. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.197 · Cited by 148
“For instance, not every individual with obesity is characterized by metabolic abnormalities that increase the risk of T2DM and cardiovascular disease”
BackgroundSelf-citationAbdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link?
Després, J. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.004 · Cited by 171
“Furthermore, as a hypertrophic fat depot not competent for hyperplasia cannot properly expand to store the extra dietary lipids, there is as a result a spillover of these triglyceride molecules leading to their accumulation at undesired sites (heart, liver, skeletal muscle, pancreas) through a process called ectopic f…”
BackgroundMethodInfluentialSelf-citationBody composition assessment for the definition of cardiometabolic risk.
Amato, M. C., Guarnotta, V., & Giordano, C. S. D. S. (2014) · PubMed · doi:10.3275/8943 · Cited by 128
“Obesity is considered the most important predisposing factor for type 2 diabetes mellitus and cardiovascular disease (1).”
BackgroundShould peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
Kunos, G., Osei-Hyiaman, D., Bátkai, S., Sharkey, K. A., & Makriyannis, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.001 · Cited by 137
“DIO in C57Bl6 mice is actually a mouse model of the metabolic syndrome, because it is accompanied by fatty liver, dyslipidemia and insulin and leptin resistance similar to the metabolic syndrome in humans [35].”
BackgroundSex differences in the impact of the Mediterranean diet on cardiovascular risk profile
Bédard, A., Riverin, M., Dodin, S., Corneau, L., & Lemieux, S. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511006969 · Cited by 138
“consequences such as improvements in insulin sensitivity and in glucose tolerance((29)).”
Adipose-derived stem cells: Fatty potentials for therapy
Ong, W. K., & Sugii, S. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.013 · Cited by 159
The Public Health Burden of Obesity in Canada
Janssen, I. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.059 · Cited by 187
Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
Konwerski, M., Gąsecka, A., Opolski, G., Grabowski, M., & Mazurek, T. (2022) · Biology · doi:10.3390/biology11030355 · Cited by 118
Shi, C., Zhu, L., Chen, X., Gu, N., Chen, L., Zhu, L., Yang, L., Pang, L., Guo, X., Ji, C., et al. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0078 · Cited by 147
“Furthermore, in visceral adipose tissue, accumulation is associated with increased mortality and risk for diabetes and insulin resistance, whereas subcutaneous adipose tissue generally serves as a storage organ (Despres and Lemieux 2006; Iozzo 2009).”
McCrindle, B. W., Mietus‐Snyder, M., Steinberger, J., Daniels, S. R., Eckel, R. H., & Hayman, L. L. (2009) · Cited by 166
Sebastiano, K. M. D., Yang, L., Zbuk, K. M., Wong, R. K. W., Chow, T., Koff, D., Moran, G. R., & Mourtzakis, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001067 · Cited by 141
“We also specifically measured VAT, as it is the most metabolically active fat tissue((9)).”
BackgroundArsenault, B. J., Côté, M., Cartier, A., Lemieux, I., Després, J.-P., Ross, R., Earnest, C. P., Blair, S. N., & Church, T. S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.009 · Cited by 132
Self-citationVisceral adiposity is negatively associated with bone density and muscle attenuation
Zhang, P., Peterson, M. D., Su, G. L., & Wang, S. C. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081778 · Cited by 143
Omentin as a novel biomarker of metabolic risk factors
Shibata, R., Ouchi, N., Takahashi, R., Terakura, Y., Ohashi, K., Ikeda, N., Higuchi, A., Terasaki, H., Kihara, S., & Murohara, T. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-37 · Cited by 134
“Individuals with excess of visceral fat accumulation have a high risk of the development of metabolic syndrome [3].”
BackgroundRull, A., Camps, J., Alonso‐Villaverde, C., & Joven, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/326580 · Cited by 160
“[33] performed a study based on the fact that some obese individuals progress to metabolic syndrome but others only have mild metabolic abnormalities [36, 37] and found that the progression of obesity-associated metabolic abnormalities is under the pathophysiological control of CD4+ T cells.”
BackgroundMa, R. C. W., Schmidt, M. I., Tam, W. H., McIntyre, H. D., & Catalano, P. M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30278-9 · Cited by 125
Daveri, E., Cremonini, E., Mastaloudis, A., Hester, S. N., Wood, S. M., Waterhouse, A. L., Anderson, M., Fraga, C. G., & Oteiza, P. I. (2018) · Redox Biology · doi:10.1016/j.redox.2018.05.012 · Cited by 141
“Thus, visceral fat accumulation is associated with the development of metabolic syndrome [24] and associated diseases, e.”
BackgroundSouza-Mello, V., Gregório, B. M., Cardoso-de-Lemos, F. S., de Carvalho, L., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2010) · Clinical Science · doi:10.1042/cs20100061 · Cited by 135
Melone, M., Wilsie, L. C., Palyha, O. C., Strack, A. M., & Rashid, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.064 · Cited by 151
“Rashid is supported in part by an Internal Career Award impairments in obesity, comprising the metabolic syndrome, is dyslipidemia (3,4).”
BackgroundAir Pollution as a Risk Factor for Type 2 Diabetes
Rao, X., Patel, P., Puett, R., & Rajagopalan, S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu250 · Cited by 132
“Inflammation is widely believed to play a key pathogenic role in the development of obesity-induced IR and T2DM (Despres and Lemieux, 2006; Horng and Hotamisligil, 2011; Hotamisligil, 2006).”
BackgroundPetta, S., Amato, M. C., Di Marco, V., Cammà, C., Pizzolanti, G., Barcellona, M. R., Cabibi, D., Galluzzo, A., Sinagra, D., Giordano, C., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04929.x · Cited by 132
Blouin, K., Nadeau, M., Perreault, M., Veilleux, A., Drolet, R., Marceau, P., Mailloux, J., Luu‐The, V., & Tchernof, A. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03645.x · Cited by 131
Chatterjee, P., Seal, S., Mukherjee, S., Kundu, R., Mukherjee, S., Ray, S., Mukhopadhyay, S., Majumdar, S. S., & Bhattacharya, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.495473 · Cited by 131
Pharmacological Stimulation of NADH Oxidation Ameliorates Obesity and Related Phenotypes in Mice
Hwang, J. H., Kim, D. W., Jo, E. J., Kim, Y. K., Jo, Y. S., Park, J. H., Yoo, S. K., Park, M. K., Kwak, T. H., Kho, Y. L., et al. (2009) · Diabetes · doi:10.2337/db08-1183 · Cited by 133
“It has been reported that the imbalance between energy intake and expenditure is clearly related to obesity and metabolic disorders (2).”
BackgroundThe weight of racism: Vigilance and racial inequalities in weight-related measures
Hicken, M. T., Lee, H., & Hing, A. K. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.03.058 · Cited by 124
“More concerning is the inequality in visceral adiposity, often proxied byWC, as this type of adiposity is a particular risk factor for many chronic diseases such as cardiovascular disease and diabetes (Despres and Lemieux, 2006; C. M. Y. Lee et al., 2008).”
BackgroundSex-based differences in insulin resistance
Gado, M., Tsaousidou, E., Bornstein, S. R., & Perakakis, N. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0245 · Cited by 139
Kitajima, Y., Hyogo, H., Sumida, Y., Eguchi, Y., Ono, N., Kuwashiro, T., Tanaka, K., Takahashi, H., Mizuta, T., Ozaki, I., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12227 · Cited by 131
Impact of cigarette smoking in type 2 diabetes development
Xie, X.-T., Liu, Q., Wu, J., & Wakui, M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.49 · Cited by 130
Cota, D. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.764 · Cited by 124
“C-reactive protein is an acutephase protein that is considered a marker of inflammation and a predictive indicator of CVD [117].”
BackgroundInfluentialMetabolic Syndrome and Insulin Resistance: Perioperative Considerations
Bagry, H., Raghavendran, S., Carli, F., Warner, D. S., & Warner, M. A. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181649314 · Cited by 152
“Genetic susceptibility, along with environmental factors such as lifestyle, diet, stress, and smoking, can trigger the development of insulin resistance.(8) The metabolic consequences, hyperinsulinemia, hyperglycemia, and lipid and lipoprotein dysregulation, act in synergy to potentiate and sustain the pathologic stat…”
BackgroundJurgoński, A., Juśkiewicz, J., & Zduńczyk, Z. (2008) · Plant Foods for Human Nutrition · doi:10.1007/s11130-008-0087-7 · Cited by 132
Chemical shift encoding‐based water–fat separation methods
Eggers, H., & Börnert, P. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24568 · Cited by 143
“10, a virtual FOV of 520 405 1630 mm3 was covered with transverse 8-mm-thick slices in a subject with a body mass index (BMI) of 35.”
BackgroundKim, K. J., Lee, M.-S., Jo, K., & Hwang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.153 · Cited by 152
“Obesity is a chronic metabolic disorder caused by energy imbalance that is characterized by increased fat mass and dysregulated lipid metabolism [1].”
BackgroundThe role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 146
“However, the excess deposition of VAT appears to play a more significant pathogenic role (Bjorntorp, 1991; Despres and Lemieux, 2006).”
BackgroundVignozzi, L., Gacci, M., Cellai, I., Morelli, A., Maneschi, E., Comeglio, P., Santi, R., Filippi, S., Sebastianelli, A., Nesi, G., et al. (2013) · The Prostate · doi:10.1002/pros.22686 · Cited by 141
“These inflammatory parameters were defined and scored as follows: prevalent anatomical location (stromal: inflammatory cells lie within prostatic stroma but not centered on prostatic glands/ducts [1]; periglandular: inflammatory infiltrates lie within stroma, are centered around ducts/glands, and approach ducts/glands…”
BackgroundMethodYuan, X., Wang, J., Yang, S., Gao, M., Cao, L., Li, X., Hong, D., Tian, S., & Sun, C. (2022) · International Journal of Endocrinology · doi:10.1155/2022/6999907 · Cited by 102
“Insensitivity and resistance to insulin are also important pathogenic mechanisms of type 2 diabetes [5].”
BackgroundØlholm, J., Paulsen, S. K., Cullberg, K. B., Richelsen, B., & Pedersen, S. B. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.98 · Cited by 135
Agrawal, S., Klarqvist, M. D. R., Diamant, N., Stanley, T. L., Ellinor, P. T., Mehta, N. N., Philippakis, A., Ng, K., Claussnitzer, M., Grinspoon, S. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35704-5 · Cited by 136
Exercise in the Metabolic Syndrome
Golbidi, S., Mesdaghinia, A., & Laher, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/349710 · Cited by 122
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Yu, S. J., Kim, W., Kim, D., Yoon, J.-H., Lee, K., Kim, J. H., Cho, E. J., Lee, J.-H., Kim, H. Y., Kim, Y. J., et al. (2015) · Medicine · doi:10.1097/md.0000000000002159 · Cited by 122
“Studies have demonstrated that VAT, which was originally considered a passive depot for energy storage, is an active endocrine tissue that releases many peptides and hormones that regulate metabnd immunity, thus participating in the D.(12,13) VAT was reported to be directly fibrosis in a biopsy-based study with a”
BackgroundAlfaro, F. J., Gavrieli, A., Saade-Lemus, P., Lioutas, V., Upadhyay, J., & Novak, V. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.009 · Cited by 133
“Obesity, mostly abdominal, is the most prevalent manifestation of MetS [87] and although most of its health consequences have been broadly examined, less is known about its effects on the brain.”
BackgroundSystematic review: chronic viral hepatitis and metabolic derangement
Wang, C., Cheng, P., & Kao, J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15575 · Cited by 133
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., & Maltais, F. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972307087205 · Cited by 145
Okauchi, Y., Nishizawa, H., Funahashi, T., Ogawa, T., Noguchi, M., Ryo, M., Kihara, S., Iwahashi, H., Yamagata, K., Nakamura, T., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0218 · Cited by 125
Fat and lean masses in youths with Down syndrome: Gender differences
González‐Agüero, A., Ara, I., Moreno, L. A., Vicente‐Rodríguez, G., & Casajús, J. A. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.02.023 · Cited by 142
“Accordingly, in our study the increase in truncal fat in females, but not in males, with DS might indicate a higher risk of metabolic syndrome and cardiovascular disease in this group (Despres & Lemieux, 2006).”
Grams, J. M., & Garvey, W. T. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0155-x · Cited by 146
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Yılmaz, M. İ., Sağlam, M., Carrero, J. J., Qureshi, A. R., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Yenicesu, M., Lindholm, B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm727 · Cited by 128
Impact of Metabolic Syndrome on Progression of Aortic Stenosis
Capoulade, R., Clavel, M.-A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., Côté, N., Mathieu, P., Després, J.-P., & Pibarot, P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.052 · Cited by 127
Self-citationBettiga, A., Fiorio, F., Di Marco, F., Trevisani, F., Romani, A., Porrini, E., Salonia, A., Montorsi, F., & Vago, R. (2019) · Nutrients · doi:10.3390/nu11081748 · Cited by 127
“Metabolic Syndrome (MS) has been directly associated to obesity in the course of the years [66].”
BackgroundCardiac adipose tissue and atrial fibrillation: the perils of adiposity
Hatem, S. N., Redheuil, A. B., & Gandjbakhch, E. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw001 · Cited by 135
Resistance training, visceral obesity and inflammatory response: a review of the evidence
Strasser, B., Arvandi, M., & Siebert, U. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.00988.x · Cited by 118
“Visceral fat increases by over 300% between the ages of 25 and 65 years, and this creates an increased risk for the development of type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD) in adults with normal body mass index (BMI) (1).”
BackgroundInfluentialShively, C. A., Register, T. C., & Clarkson, T. B. (2009) · American Journal of Primatology · doi:10.1002/ajp.20706 · Cited by 121
“Metabolic syndrome also increases the risk of other diseases and disorders including type 2 diabetes mellitus [Després & Lemieux, 2006].”
BackgroundMetabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links
He, Q., Wang, Z., Liu, G., Daneshgari, F., MacLennan, G. T., & Gupta, S. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.43 · Cited by 136
Jiang, Z., Zhao, M., Zhang, H., Li, Y., Liu, M., & Feng, F. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700547 · Cited by 125
“The five screening components used to identify those with metabolic syndrome are fasting plasma glucose, abdominal obesity, circulating levels of triacylglycerols, high-density lipoprotein (HDL)-cholesterol and blood pressure [3].”
MethodBourebaba, L., & Marycz, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122033 · Cited by 137
“Obesity-associated lipolysis triggers the generation and release of free fatty acids into the bloodstream in excess, subsequently increasing chronic subclinical inflammation, thereby exacerbating pre-existing insulin resistance in various targeted tissues [57,58].”
BackgroundInfluence of Cardiometabolic Risk Factors on Platelet Function
Barale, C., & Russo, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020623 · Cited by 133
“In fact, abdominal adiposity may have a causal, unfavorable effect on plasma triglycerides (TGs) and potentially other cardiometabolic risk factors due to a greater ability to release cytokines and free fatty acids involved in the pathogenesis of both atherothrombosis and insulin resistance [9,10].”
Background
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.